A Unique Model for Evidence-Based Products
Most healthcare professionals acknowledge the medicinal potential of cannabis, however wide the adoption of the cannabis derived medicinal products is hindered by the lack of relevant “evidence-based” human clinical studies and an unclear regulatory pathway. Despite the recent increase in the number of cannabis clinical and preclinical studies, the majority of the currently marketed cannabis derived products lack any evidence of safety and efficacy.
Sadé has recruited prominent Israeli scientists to introduce a model that will help develop and support the "evidence-based" paradigm, with a special attention to the needs of the patients, scientific community, regulators and industry.
This approach is applied to all pre-clinical and clinical studies conducted by Sadé and its researchers. The results of these studies are documented in a knowledge-based center and compared with past studies and aligned with Sadé elaborated plant genetic library
Sadé Clinical Studies
Our mission is to spread the knowledge and create interest by conducting multinational pre-clinical and clinical studies.
Researchers in the field that wish to collaborate with our Israeli teams in such bilateral research programs, please click here to connect